Abstract

Prions are infectious agents that cause neurodegenerative diseases such as Creutzfeldt-Jakob disease (CJD). The absence of a human cell culture model that replicates human prions has hampered prion disease research for decades. In this paper, we show that astrocytes derived from human induced pluripotent stem cells (iPSCs) support the replication of prions from brain samples of CJD patients. For experimental exposure of astrocytes to variant CJD (vCJD), the kinetics of prion replication occur in a prion protein codon 129 genotype-dependent manner, reflecting the genotype-dependent susceptibility to clinical vCJD found in patients. Furthermore, iPSC-derived astrocytes can replicate prions associated with the major sporadic CJD strains found in human patients. Lastly, we demonstrate the subpassage of prions from infected to naive astrocyte cultures, indicating the generation of prion infectivity in vitro. Our study addresses a long-standing gap in the repertoire of human prion disease research, providing a new in vitro system for accelerated mechanistic studies and drug discovery.

Highlights

  • Prions are protein-based transmissible pathogens responsible for fatal neurodegenerative diseases of the central nervous system (CNS), such as Creutzfeldt–Jakob disease (CJD; Prusiner, 2013)

  • Characterization of human induced pluripotent stem cell (iPSC)–derived astrocyte progenitor cells (APCs) and astrocyte cultures Astrocytes were generated from iPSC lines using a previously established protocol (Fig. 1 A; Krencik and Zhang, 2011; Serio et al, 2013)

  • After prion protein gene (PRNP) genotyping, two methionine/ methionine (MM), one MV, and one VV cell line were selected for the generation of APCs and astrocytes

Read more

Summary

Introduction

Prions are protein-based transmissible pathogens responsible for fatal neurodegenerative diseases of the central nervous system (CNS), such as Creutzfeldt–Jakob disease (CJD; Prusiner, 2013).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call